| Chirocare Center | |
|
124 Maine St Ste 215, Brunswick, ME 04011-2078 | |
| (207) 729-4645 | |
| (207) 721-1189 |
| Full Name | Chirocare Center |
|---|---|
| Type | Facility |
| Speciality | Chiropractor |
| Location | 124 Maine St Ste 215, Brunswick, Maine |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1982059622 | NPI | - | NPPES |
| 1063517837 | Other | INDIVIDUAL NPI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 111N00000X | Chiropractor | CR1356 (Maine) | Primary |
| Provider Name | Jason B Steinhouser |
|---|---|
| Provider Type | Practitioner - Chiropractic |
| Provider Identifiers | NPI Number: 1063517837 PECOS PAC ID: 9234205345 Enrollment ID: I20080912000527 |
News Archive
Halozyme Therapeutics, Inc., a biotechnology company developing novel oncology and drug-delivery therapies, today announced the first patient has been dosed in its Halo-301 | Pancreatic study, a Phase 3 clinical trial in previously untreated metastatic pancreatic cancer patients.
The European Society of Cardiology has launched a novel position paper, under the auspices of its Committee for Practice Guidelines, on tackling the cardiac toxicity of anticancer therapies. The cardio-oncology paper is published online today in European Heart Journal and on the ESC Website.
Solta Medical, Inc., a global leader in the medical aesthetics market, today announced it has entered into a definitive agreement to acquire privately-held Aesthera Corporation, which is based in Pleasanton, California. Under the terms of the definitive agreement, Solta will acquire Aesthera for $5.25 million in Solta common stock and cash, with potential additional base line milestones of $750,000 for a consideration of $6.0 million. Excluding acquisition and integration related charges, the transaction is expected to be accretive to Solta Medical's earnings within twelve months.
Major amputation is often selected over infrainguinal bypass in patients with severe systemic comorbidities because of a presumed decrease in risk of perioperative morbidity and mortality. To investigate this presumption, researchers from the Division of Vascular and Endovascular Surgery at the Brigham and Women's Hospital in Boston undertook a risk-adjusted comparison of early postoperative morbidity and mortality of high-risk patients undergoing infrainguinal bypass and major amputation.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Chirocare Center 124 Maine St Ste 215, Brunswick, ME 04011-2078 Ph: (207) 729-4645 | Chirocare Center 124 Maine St Ste 215, Brunswick, ME 04011-2078 Ph: (207) 729-4645 |
News Archive
Halozyme Therapeutics, Inc., a biotechnology company developing novel oncology and drug-delivery therapies, today announced the first patient has been dosed in its Halo-301 | Pancreatic study, a Phase 3 clinical trial in previously untreated metastatic pancreatic cancer patients.
The European Society of Cardiology has launched a novel position paper, under the auspices of its Committee for Practice Guidelines, on tackling the cardiac toxicity of anticancer therapies. The cardio-oncology paper is published online today in European Heart Journal and on the ESC Website.
Solta Medical, Inc., a global leader in the medical aesthetics market, today announced it has entered into a definitive agreement to acquire privately-held Aesthera Corporation, which is based in Pleasanton, California. Under the terms of the definitive agreement, Solta will acquire Aesthera for $5.25 million in Solta common stock and cash, with potential additional base line milestones of $750,000 for a consideration of $6.0 million. Excluding acquisition and integration related charges, the transaction is expected to be accretive to Solta Medical's earnings within twelve months.
Major amputation is often selected over infrainguinal bypass in patients with severe systemic comorbidities because of a presumed decrease in risk of perioperative morbidity and mortality. To investigate this presumption, researchers from the Division of Vascular and Endovascular Surgery at the Brigham and Women's Hospital in Boston undertook a risk-adjusted comparison of early postoperative morbidity and mortality of high-risk patients undergoing infrainguinal bypass and major amputation.
› Verified 6 days ago
Jason Bryan Steinhouser, D.C. Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 124 Maine St Ste 215, Brunswick, ME 04011 Phone: 207-729-4645 Fax: 207-721-1189 | |
Jeffrey S Slocum, D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 26 Bath Rd, Suite #1, Brunswick, ME 04011 Phone: 207-725-4222 Fax: 207-319-7046 | |
Hagerty Chiropractic Chiropractor Medicare: Medicare Enrolled Practice Location: 298 Maine St, Brunswick, ME 04011 Phone: 207-729-8656 Fax: 207-729-7471 | |
Dr. Elizabeth Maeve Mcnally, DC. DACNB Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 331 Maine St Ste 12, Brunswick, ME 04011 Phone: 207-406-4874 Fax: 207-560-9376 | |
Dr. Thomas J. Augat, D.C. Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 9 Pleasant St, Brunswick, ME 04011 Phone: 207-725-7177 Fax: 207-725-5600 | |
Slocum Family Chiropractic Pa Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 26 Bath Rd, Suite 1, Brunswick, ME 04011 Phone: 207-725-4222 | |
Dustin A Slocum, DC Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 26 Bath Rd, Suite #1, Brunswick, ME 04011 Phone: 207-725-4222 Fax: 207-319-7046 |